Lorlatinib
Product Specifications
CAS Number
1454846-35-5
Target
ROS Kinase|||Apoptosis|||ROS|||ALK|||Tyrosine Kinases
Related Pathways
Angiogenesis|||Tyrosine Kinase/Adaptors|||Immunology/Inflammation|||Apoptosis
Purity
0.9995
Bioactivity
Lorlatinib (PF-6463922) is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity.
Smiles
C[C@H]1Oc2cc(cnc2N)-c2c(CN(C)C(=O)c3ccc(F)cc13)nn(C)c2C#N
Molecular Formula
C21H19FN6O2
Molecular Weight
406.41
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1028077-01 0.02 mg (E-Coli)
Recombinant Human parainfluenza 2 virus Non-structural protein V (P/V)
Ask
View Details 
MBS1028077-02 0.1 mg (E-Coli)
Recombinant Human parainfluenza 2 virus Non-structural protein V (P/V)
Ask
View Details MBS1028077-03 0.02 mg (Yeast)
Recombinant Human parainfluenza 2 virus Non-structural protein V (P/V)
Ask
View Details 
MBS1028077-04 0.1 mg (Yeast)
Recombinant Human parainfluenza 2 virus Non-structural protein V (P/V)
Ask
View Details MBS1028077-05 0.02 mg (Baculovirus)
Recombinant Human parainfluenza 2 virus Non-structural protein V (P/V)
Ask
View Details MBS1028077-06 0.02 mg (Mammalian-Cell)
Recombinant Human parainfluenza 2 virus Non-structural protein V (P/V)
Ask
View Details